Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
688289:SHA
Sansure Biotech Inc
CN¥17.41
+0.58%
(+0.10) 1D
May 22, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688289...
Open
CN¥17.27
High
CN¥17.51
Low
CN¥17.20
Mkt. cap
10.09B
Avg. vol.
4.61M
Volume
2.71M
P/E ratio
66.26
52-wk high
CN¥23.45
52-wk low
CN¥17.07
EPS
CN¥0.26
No. of employees
2K
News stories
From sources across the web
About Sansure Biotech Inc
CEO-
Employees2.13K
FoundedApr 23, 2008
Headquarters-
SectorMedical device
Websitesansure.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
393.13M
375.52M
397.39M
437.35M
Cost of goods sold
113.49M
112.00M
61.26M
116.71M
Cost of revenue
113.49M
112.00M
61.26M
116.71M
Research and development expenses
59.39M
60.42M
50.27M
56.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
173.50M
212.04M
229.33M
205.78M
Operating expense
242.90M
246.86M
271.53M
260.62M
Total operating expenses
356.39M
358.85M
332.79M
377.33M
Operating income
36.74M
16.66M
64.60M
60.01M
Other non operating income
-3.09M
1.83M
2.54M
-388.10K
EBT including unusual items
71.46M
9.17M
-4.69M
51.12M
EBT excluding unusual items
51.41M
31.64M
19.14M
52.26M
Income tax expense
9.35M
-10.07M
3.36M
9.32M
Effective tax rate
13.09%
-109.87%
-71.66%
18.24%
Other operating expenses
4.07M
-12.07M
-8.07M
-1.69M
Net income
70.98M
28.60M
7.62M
49.74M
Net profit margin
18.06%
7.62%
1.92%
11.37%
Earnings per share
-
-
-
-
Interest and investment income
22.08M
20.30M
17.57M
-
Interest expense
-5.11M
-6.35M
-65.58M
-
Net interest expenses
16.97M
13.94M
-48.01M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
82.75M
51.82M
115.54M
110.96M
Gain or loss from assets sale
3.04M
-3.04M
2.95M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer